Global Cost Effective Analysis Of Apixaban Versus Warfarin For The Prevention Of Stroke As A Result Of Atrial Fibrillation: A Systematic Review
Document Type
Abstract
Publication Date
2018
Recommended Citation
Petrenchik, L., Hussain, N., Charles, P., Peprah, H., & Loh, F. E. (2018). Global Cost Effective Analysis Of Apixaban Versus Warfarin For The Prevention Of Stroke As A Result Of Atrial Fibrillation: A Systematic Review. Value in Health, 21 (Suppl. 1), S61. https://doi.org/10.1016/j.jval.2018.04.372
Publisher's Statement
The original material can be found here: https://doi.org/10.1016/j.jval.2018.04.372
